AbbVie Inc. (ABBV) vs Roche Holding AG (RHHBY)
A side-by-side comparison of AbbVie Inc. and Roche Holding AG across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 27, 2026. Differences are shown without an overall score or investment verdict.
ABBV
AbbVie Inc.
$258.02HealthcareDelayed quote: Aug 27, 2026, 3:59 PM EDT
RHHBY
Roche Holding AG
$56.39HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT
Total return — ABBV vs RHHBY
growth of $100 · dividends reinvested · last 10yABBV +514.6% (+19.9%/yr)RHHBY +146.1% (+9.4%/yr)ABBV compounded faster over this window
ABBV RHHBY
ABBV vs RHHBY: by the numbers
- •ABBV is the larger company ($455.87B vs $359.46B market cap).
- •RHHBY trades at the lower trailing earnings multiple (16.15 vs 74.07 P/E), one valuation lens rather than an overall verdict.
- •RHHBY converts more revenue to profit (20.33% vs 9.81% net margin).
- •RHHBY grew revenue faster over the past five years (3.94% vs 3.69% CAGR).
- •RHHBY pays the higher dividend yield (2.75% vs 2.60%).
Metrics side by side
Valuation
| Metric | ABBV | RHHBY |
|---|---|---|
| P/E ratio | 74.07 | 16.15 |
| Forward P/E | 18.74 | 22.83 |
| P/S ratio | 7.23 | 4.53 |
| P/B ratio | N/A | 9.06 |
| EV / EBITDA | 19.77 | 14.21 |
| FCF yield | 4.23% | 4.69% |
Profitability
| Metric | ABBV | RHHBY |
|---|---|---|
| Gross margin | 71.48% | 73.73% |
| Operating margin | 29.32% | 29.16% |
| Net margin | 9.81% | 20.33% |
| ROE | -129.24% | 38.06% |
| ROIC | 13.46% | 19.71% |
Dividends
| Metric | ABBV | RHHBY |
|---|---|---|
| Dividend yield | 2.60% | 2.75% |
| Payout ratio | 288.19% | 60.81% |
Growth (annualized)
| Metric | ABBV | RHHBY |
|---|---|---|
| Revenue CAGR (5Y) | 3.69% | 3.94% |
| EPS CAGR (5Y) | -2.79% | 1.54% |
| FCF CAGR (5Y) | 0.11% | 5.54% |
| Total return CAGR (5Y) | 21.30% | 5.84% |
Frequently asked
- Which has the lower trailing P/E, ABBV or RHHBY?
- RHHBY has the lower trailing P/E: ABBV trades at 74.07 and RHHBY at 16.15. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABBV or RHHBY?
- Over the past five years, RHHBY grew revenue faster — ABBV at a 3.69% CAGR versus RHHBY at 3.94%.
- Does ABBV or RHHBY pay a bigger dividend?
- ABBV yields 2.60% and RHHBY yields 2.75% based on trailing dividends and the latest price.
- Is ABBV or RHHBY more profitable?
- RHHBY runs the higher net margin — ABBV at 9.81% versus RHHBY at 20.33%.
- How have ABBV and RHHBY total returns compared?
- Over the past 10 years, ABBV delivered 19.90% and RHHBY delivered 9.59% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioRoche Holding AG P/E ratioAbbVie dividend yieldRoche Holding AG dividend yieldAbbVie ROERoche Holding AG ROEAbbVie operating marginRoche Holding AG operating marginAbbVie revenue growthRoche Holding AG revenue growthAbbVie free cash flowRoche Holding AG free cash flow
AbbVie & Roche Holding AG appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 27, 2026.